| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-325
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C275-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-27 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-27
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C275-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 |
| filingDate |
2015-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2017-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2017512211-A |
| titleOfInvention |
Aminocarbonyl carbamate compounds |
| abstract |
The present invention is effective as a dopamine reabsorption inhibitor of formula (I) And a pharmaceutically acceptable salt thereof, and a method of using the compound. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2020503246-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2019533640-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-7074750-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-7219213-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-7148498-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11560354-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2019535643-A |
| priorityDate |
2014-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |